ASN824

GlaxoSmithKline

Regional Internet registrar: American Registry for Internet Numbers – ARIN
Registration date: 29 March 1994
Organization ID: GLAXOSMITHKLINE
Country: United States
City: Philadelphia
Address: 5 Crescent Drive
Homepage: gsk.com

IP ranges

Range:
Number of addresses in the block:
Description:
Domains:
145.240.6.0 - 145.240.7.255
512
145.240.6.0/23
-

Last update: 2024-05-14 13:33:31


WHOIS description


#
# ARIN WHOIS data and services are subject to the Terms of Use
# available at: https://www.arin.net/resources/registry/whois/tou/
#
# If you see inaccuracies in the results, please report at
# https://www.arin.net/resources/registry/whois/inaccuracy_reporting/
#
# Copyright 1997-2024, American Registry for Internet Numbers, Ltd.
#


#
# Query terms are ambiguous.  The query is assumed to be:
#     "a 824"
#
# Use "?" to get help.
#

ASNumber:       824
ASName:         GLAXOSMITHKLINE
ASHandle:       AS824
RegDate:        1994-03-29
Updated:        2007-06-08    
Ref:            https://rdap.arin.net/registry/autnum/824


OrgName:        GlaxoSmithKline
OrgId:          SBC-92
Address:        5 Crescent Drive
City:           Philadelphia
StateProv:      PA
PostalCode:     19112
Country:        US
RegDate:        2007-03-13
Updated:        2021-02-10
Ref:            https://rdap.arin.net/registry/entity/SBC-92


OrgTechHandle: GSKTE-ARIN
OrgTechName:   GSK-TECH
OrgTechPhone:  +1-610-962-4025 
OrgTechEmail:  addrmgmt@gsk.com
OrgTechRef:    https://rdap.arin.net/registry/entity/GSKTE-ARIN

OrgAbuseHandle: GSKCS-ARIN
OrgAbuseName:   GSK-CSIR
OrgAbusePhone:  +1-215-751-4000 
OrgAbuseEmail:  csir@gsk.com
OrgAbuseRef:    https://rdap.arin.net/registry/entity/GSKCS-ARIN


#
# ARIN WHOIS data and services are subject to the Terms of Use
# available at: https://www.arin.net/resources/registry/whois/tou/
#
# If you see inaccuracies in the results, please report at
# https://www.arin.net/resources/registry/whois/inaccuracy_reporting/
#
# Copyright 1997-2024, American Registry for Internet Numbers, Ltd.
#